首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1306058

代謝體學:全球市場的展望·預測 (2023-2028年)

Metabolomics Market - Global Outlook & Forecast 2023-2028

出版日期: 2023年07月12日 | 出版商:

Arizton Advisory & Intelligence | 英文 305 Pages | 訂單完成後即時交付

價格

簡介目錄

預計2022年至2028年全球代謝組學市場規模將以12.84%的複合年增長率增長。

代謝組學正在成為食品安全和質量控制日益重要的工具。代謝組學使研究人員和生產商能夠評估食品的化學成分、檢測潛在有害物質並監測總體食品質量。預計這些因素將對代謝組學市場的增長產生積極影響。代謝組學也是一個快速發展的研究領域，已應用於癌症、糖尿病、肥胖症、心臟病、阿爾茨海默病、帕金森病等多種疾病的研究。

本報告提供全球代謝體學的市場調查，彙整市場定義和概要，市場機會·市場趨勢，市場影響因素的分析，市場規模的轉變·預測，各種區分·各地區的詳細分析，競爭情形，主要企業簡介等資訊。

Metabolomics is becoming an increasingly important tool for food safety and quality control due to its ability to analyze the chemicals produced by organisms as they interact with their environment. Metabolomics allows researchers and producers to assess food's chemical composition, enabling them to detect potentially harmful substances and monitor the overall quality of food. Such factors are projected to affect the metabolomics market growth positively. Metabolomics can also identify adulterated foods, diagnose food-related illnesses, and determine the chemical composition of food-processing by-products. All of these uses can help producers provide consumers with safer and higher-quality food products and help ensure compliance with food safety regulations.

Increasing Funding for Metabolomics Research

Increasing funding for metabolomics research would allow researchers to explore further the biochemical processes occurring in organisms. Metabolomics studies the comprehensive view of all the molecules, or metabolites, in the body, which provides an in-depth understanding of the metabolic networks involved in diverse physiological and pathological conditions. More resources allocated to this field of research would enable scientists to understand better the connections between molecular events and their effects on an organism's health. Research studies may also identify novel biomarkers that target specific aspects of metabolism, potentially aiding in developing more effective diagnostics for diseases and other conditions. Additionally, increased investment in metabolomics could facilitate the discovery of new drug targets and lead to the development of drugs with fewer side effects. The implications of research in this field can lead to a better understanding of the metabolic pathways in humans and other organisms and ultimately provide more personalized and effective treatments.

Growing Rate of Target Diseases

Metabolomics is a rapidly growing field of research that is being applied to studying various diseases, including cancer, diabetes, obesity, heart disease, Alzheimer's disease, and Parkinson's disease. By studying the different metabolites in an individual's body, researchers can gain valuable insight into the biochemical processes and potential causes of various diseases. The metabolomics market has paved the way to provide a better understanding of the molecular pathways and biochemical processes involved in the progression of a particular disease. By studying the metabolic pathways of a given disease, it may be possible to identify potential targets for therapeutic interventions.

SEGMENTATION INSIGHTS

INSIGHTS BY TECHNOLOGIES

The detection method technologies segment dominated the global metabolomics market, with a share of over 44% in 2022. Metabolomics is a powerful tool in biology and biochemistry, providing insights into the body's metabolic and physiological processes. Over the last decade, technological advances have made metabolomics increasingly accessible and powerful. One important technology used in metabolomics is mass spectrometry. Mass spectrometry involves passing an ionized sample through a vacuum chamber, where it is broken down into its component elements. These mass spectra can then be used to identify and quantify the different metabolites present in a sample. Mass spectrometry is used in metabolomics to analyze complex metabolic mixtures and to determine the concentration of various metabolites in a sample.

Segmentation by Technologies

Detection Methods
Separation Methods
Bioinformatics Tools & Services

INSIGHTS BY APPLICATION

The global metabolomics market by application is segmented into medical & clinical research, plant & food science, and biotechnology. Metabolomics is an ever-growing field of research that is gaining increasing attention due to its potential in medical and clinical applications. The medical and clinical applications of metabolomics are numerous. They can be used to diagnose and monitor diseases and study the effects of drugs, toxins, and other environmental factors on health. Metabolomics can provide insight into the molecular basis of diseases and the mechanisms of the action of drugs. This information can be used to improve drug design and to identify novel therapeutic targets. Metabolomics can also be used to predict drug response in individuals and to identify biomarkers that can be used to evaluate health status. Such factors have helped the medical & clinical research application segment to dominate the global metabolomics market during the forecast period.

Segmentation by Application

Medical & Clinical Research
Plant & Food Science
Biotechnology

INSIGHTS BY END-USER

The standalone metabolomics service providers segment accounted for the largest global metabolomics market share in 2022. Metabolomics service providers are becoming increasingly important in the field of research. By offering specialized services, such as sample preparation and analysis, data analysis and interpretation, and metabolite identification and quantification, these companies are helping researchers better understand how cells work and how diseases develop. As the demand for metabolomics services continues to grow, more companies are entering the market and offering specialized services to meet the needs of researchers.

Segmentation by End-user

Standalone Metabolomic Service Providers
Pharma & Biotech Companies
Research & Clinical Laboratories
Others

GEOGRAPHICAL ANALYSIS

North America dominated the global metabolomics market share, accounting for over 40% in 2022, mainly due to the developed infrastructure, increased government projects based on various new biological compound syntheses, advances in metabolomics technologies, and many research laboratories performing studies on various diseases. Metabolomics also has a wide range of applications other than healthcare, such as plant & food science, biofuel, and bioengineering. The most important factor that drives the regional market is the rise in investments in metabolomics. The major contributors in North America are the U.S. and Canada. Arizton predicts that the market in this region will grow at a healthy rate and dominate the global metabolomics market during the forecast period.

Segmentation By Geography

North America
- The U.S.
- Canada
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
APAC
- China
- Japan
- India
- South Korea
- Australia
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia

COMPETITIVE LANDSCAPE

The global metabolomics market is highly competitive and dynamic due to several international, regional, and local players offering comprehensive metabolomics solutions. Rapid technological changes, frequent new product launches, and changes in industry standards characterize the market. Several companies are compelled to invest in new product development and product enhancement initiatives based on recent technological innovations so that their products are not rendered obsolete over time. Pharmaceutical companies, research and diagnostic laboratories, and healthcare establishments use metabolomics products. Launching more efficient and economical products will result in faster adoption and revolutionize the market.

Key Company Profiles

Agilent Technologies
Bio-Rad Laboratories
Danaher
PerkinElmer
Thermo Fisher Scientific

Other Prominent Vendors

Advion
BGI
biocrates life sciences
Bruker
LECO
Merck KGaA
SCION Instruments
Shimadzu Corporation
Waters

KEY QUESTIONS ANSWERED:

1. How big is the metabolomics market?
2. What is the growth rate of the metabolomics market?
3. What are the rising trends in the metabolomics market?
4. Which region holds the most significant global metabolomics market share?
5. Who are the key players in the global metabolomics market?

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY TECHNOLOGY
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY END-USER
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 OVERVIEW
- 6.1.1 GEOGRAPHY SEGMENTATION INSIGHTS
- 6.1.2 TECHNOLOGY SEGMENTATION INSIGHTS
- 6.1.3 APPLICATION SEGMENTATION INSIGHTS
- 6.1.4 END-USER SEGMENTATION INSIGHTS

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 METABOLOMICS IN PLANT & ENVIRONMENTAL STUDIES
9.2 DEMAND FOR METABOLOMICS IN FOOD SAFETY & QUALITY CONTROL
9.3 INCREASED FUNDING FOR METABOLOMICS RESEARCH

10 MARKET GROWTH ENABLERS

10.1 APPLICATION OF METABOLOMICS IN PRECISION MEDICINE
10.2 INCREASED RATE OF TARGET DISEASES
10.3 DEMAND FOR METABOLOMICS IN DRUG DEVELOPMENT

11 MARKET RESTRAINTS

11.1 COMPLEXITY & DIVERSITY OF BIOLOGICAL SAMPLES
11.2 HIGH COST OF TOOLS & INSTRUMENTS
11.3 ISSUES RELATED TO EXAMINATION & DATA PROCESSING

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 MARKET OPPORTUNITIES
- 12.3.1 MARKET BY GEOGRAPHY
- 12.3.2 MARKET BY TECHNOLOGY
- 12.3.3 MARKET BY APPLICATION
- 12.3.4 MARKET BY END-USER
12.4 FIVE FORCES ANALYSIS
- 12.4.1 THREAT OF NEW ENTRANTS
- 12.4.2 BARGAINING POWER OF SUPPLIERS
- 12.4.3 BARGAINING POWER OF BUYERS
- 12.4.4 THREAT OF SUBSTITUTES
- 12.4.5 COMPETITIVE RIVALRY

13 TECHNOLOGY

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 DETECTION METHODS
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 DETECTION METHODS BY GEOGRAPHY
13.4 SEPARATION METHODS
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 SEPARATIONS METHOD BY GEOGRAPHY
13.5 BIOINFORMATICS TOOLS & SERVICES
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 BIOINFORMATICS TOOLS & SERVICES BY GEOGRAPHY

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MEDICAL & CLINICAL RESEARCH
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MEDICAL & CLINICAL RESEARCH BY GEOGRAPHY
14.4 PLANT & FOOD SCIENCE
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 PLANT & FOOD SCIENCE BY GEOGRAPHY
14.5 BIOTECHNOLOGY
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 BIOTECHNOLOGY BY GEOGRAPHY

15 END-USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 STANDALONE METABOLOMICS SERVICE PROVIDERS
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 STANDALONE METABOLOMICS SERVICE PROVIDERS BY GEOGRAPHY
15.4 PHARMA & BIOTECH COMPANIES
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
15.5 RESEARCH & CLINICAL LABORATORIES
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.5.3 RESEARCH & CLINICAL LABORATORIES BY GEOGRAPHY
15.6 OTHERS
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.6.3 OTHERS BY GEOGRAPHY

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW

17 NORTH AMERICA

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
- 17.2.1 NORTH AMERICA MARKET BY TECHNOLOGY
- 17.2.2 NORTH AMERICA MARKET BY APPLICATION
- 17.2.3 NORTH AMERICA MARKET BY END-USER
17.3 KEY COUNTRIES
- 17.3.1 US: MARKET SIZE & FORECAST
- 17.3.2 CANADA: MARKET SIZE & FORECAST

18 EUROPE

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
- 18.2.1 EUROPE MARKET BY TECHNOLOGY
- 18.2.2 EUROPE MARKET BY APPLICATION
- 18.2.3 EUROPE MARKET BY END-USER
18.3 KEY COUNTRIES
- 18.3.1 GERMANY: MARKET SIZE & FORECAST
- 18.3.2 FRANCE: MARKET SIZE & FORECAST
- 18.3.3 UK: MARKET SIZE & FORECAST
- 18.3.4 ITALY: MARKET SIZE & FORECAST
- 18.3.5 SPAIN: MARKET SIZE & FORECAST

19 APAC

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
- 19.2.1 APAC MARKET BY TECHNOLOGY
- 19.2.2 APAC MARKET BY APPLICATION
- 19.2.3 APAC MARKET BY END-USER
19.3 KEY COUNTRIES
- 19.3.1 CHINA: MARKET SIZE & FORECAST
- 19.3.2 JAPAN: MARKET SIZE & FORECAST
- 19.3.3 INDIA: MARKET SIZE & FORECAST
- 19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 19.3.5 AUSTRALIA: MARKET SIZE & FORECAST

20 LATIN AMERICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
- 20.2.1 LATIN AMERICA MARKET BY TECHNOLOGY
- 20.2.2 LATIN AMERICA MARKET BY APPLICATION
- 20.2.3 LATIN AMERICA MARKET BY END-USER
20.3 KEY COUNTRIES
- 20.3.1 BRAZIL: MARKET SIZE & FORECAST
- 20.3.2 MEXICO: MARKET SIZE & FORECAST
- 20.3.3 ARGENTINA: MARKET SIZE & FORECAST

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
- 21.2.1 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
- 21.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
- 21.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
21.3 KEY COUNTRIES
- 21.3.1 TURKEY: MARKET SIZE & FORECAST
- 21.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
- 21.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
- 22.2.1 AGILENT TECHNOLOGIES
- 22.2.2 BIO-RAD LABORATORIES
- 22.2.3 DANAHER
- 22.2.4 PERKINELMER
- 22.2.5 THERMO FISHER SCIENTIFIC

23 KEY COMPANY PROFILES

23.1 AGILENT TECHNOLOGIES
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.1.3 KEY STRATEGIES
- 23.1.4 KEY STRENGTHS
- 23.1.5 KEY OPPORTUNITIES
23.2 BIO-RAD LABORATORIES
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
23.3 DANAHER
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES
23.4 PERKINELMER
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.4.3 KEY STRATEGIES
- 23.4.4 KEY STRENGTHS
- 23.4.5 KEY OPPORTUNITIES
23.5 THERMO FISHER SCIENTIFIC
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
- 23.5.3 KEY STRATEGIES
- 23.5.4 KEY STRENGTHS
- 23.5.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

24.1 ADVION
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
24.2 BGI
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
24.3 BIOCRATES LIFE SCIENCES
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
24.4 BRUKER
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
24.5 LECO
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
24.6 MERCK KGAA
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
24.7 SCION INSTRUMENTS
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
24.8 SHIMADZU CORPORATION
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
24.9 WATERS
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS

25 METABOLOMICS SERVICE PROVIDERS

25.1 CREATIVE PROTEOMICS
- 25.1.1 BUSINESS OVERVIEW
- 25.1.2 PRODUCT OFFERINGS
25.2 HUMAN METABOLOME TECHNOLOGIES
- 25.2.1 BUSINESS OVERVIEW
- 25.2.2 PRODUCT OFFERINGS
25.3 METABOLON
- 25.3.1 BUSINESS OVERVIEW
- 25.3.2 SERVICE OFFERINGS
25.4 METWARE BIOTECHNOLOGY
- 25.4.1 BUSINESS OVERVIEW
- 25.4.2 PRODUCT OFFERINGS
25.5 MS-OMICS
- 25.5.1 BUSINESS OVERVIEW
- 25.5.2 PRODUCT OFFERINGS
25.6 VPROTEOMICS
- 25.6.1 BUSINESS OVERVIEW
- 25.6.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY TECHNOLOGY
- 27.1.1 NORTH AMERICA MARKET BY TECHNOLOGY
- 27.1.2 EUROPE MARKET BY TECHNOLOGY
- 27.1.3 APAC MARKET BY TECHNOLOGY
- 27.1.4 LATIN AMERICA MARKET BY TECHNOLOGY
- 27.1.5 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
27.2 MARKET BY APPLICATION
- 27.2.1 NORTH AMERICA MARKET BY APPLICATION
- 27.2.2 EUROPE MARKET BY APPLICATION
- 27.2.3 APAC MARKET BY APPLICATION
- 27.2.4 LATIN AMERICA MARKET BY APPLICATION
- 27.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
27.3 MARKET BY END-USER
- 27.3.1 NORTH AMERICA MARKET BY END-USER
- 27.3.2 EUROPE MARKET BY END-USER
- 27.3.3 APAC MARKET BY END-USER
- 27.3.4 LATIN AMERICA MARKET BY END-USER
- 27.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
27.4 MARKET BY GEOGRAPHY
- 27.4.1 DETECTION METHODS BY GEOGRAPHY
- 27.4.2 SEPARATION METHODS BY GEOGRAPHY
- 27.4.3 BIOINFORMATICS TOOLS & SERVICES BY GEOGRAPHY
- 27.4.4 MEDICAL & CLINICAL RESEARCH BY GEOGRAPHY
- 27.4.5 PLANT & FOOD SCIENCE BY GEOGRAPHY
- 27.4.6 BIOTECHNOLOGY BY GEOGRAPHY
- 27.4.7 STANDALONE METABOLOMICS SERVICE PROVIDERS BY GEOGRAPHY
- 27.4.8 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
- 27.4.9 RESEARCH & CLINICAL LABORATORIES BY GEOGRAPHY
- 27.4.10 OTHERS BY GEOGRAPHY